Cite

    Assimon, M. et al. (2022). Proton pump inhibitors may enhance the risk of citalopram‐ and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiology and drug safety. 31 (6), pp. 670-679. [Online].